Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus
A. Harstrick(Merck KGaA, Darmstadt (Germany)), H. Wilke(Kliniken Essen-Mitte), Carsten Bokemeyer(Universität Hamburg), P. Preusser(University Hospital Münster), Hans‐Joachim Schmoll(Martin Luther University Halle-Wittenberg), Claus Henning K�hne-W�mpner(Medizinische Hochschule Hannover), Hans‐Joachim Meyer, H. Knipp(Alfried Krupp Hospital), Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 32
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k